Implementation of a Leave-behind Naloxone Program in San Francisco: A One-year Experience.
Journal
The western journal of emergency medicine
ISSN: 1936-9018
Titre abrégé: West J Emerg Med
Pays: United States
ID NLM: 101476450
Informations de publication
Date de publication:
31 Oct 2022
31 Oct 2022
Historique:
received:
27
02
2022
accepted:
16
08
2022
entrez:
21
11
2022
pubmed:
22
11
2022
medline:
24
11
2022
Statut:
epublish
Résumé
In response to the ongoing opioid overdose crisis, US officials urged the expansion of access to naloxone for opioid overdose reversal. Since then, emergency medical services' (EMS) dispensing of naloxone kits has become an emerging harm reduction strategy. We created a naloxone training and low-barrier distribution program in San Francisco: Project FRIEND (First Responder Increased Education and Naloxone Distribution). The team assembled an advisory committee of stakeholders and subject-matter experts, worked with local and state EMS agencies to augment existing protocols, created training curricula, and developed a naloxone-distribution data collection system. Naloxone kits were labeled for registration and data tracking. Emergency medical technicians and paramedics were asked to distribute naloxone kits to any individuals (patient or bystander) they deemed at risk of experiencing or witnessing an opioid overdose, and to voluntarily register those kits. Training modalities included a video module (distributed to over 700 EMS personnel) and voluntary, in-person training sessions, attended by 224 EMS personnel. From September 25, 2019-September 24, 2020, 1,200 naloxone kits were distributed to EMS companies. Of these, 232 kits (19%) were registered by EMS personnel. Among registered kits, 146 (63%) were distributed during encounters for suspected overdose, and 103 (44%) were distributed to patients themselves. Most patients were male (n = 153, 66%) and of White race (n = 124, 53%); median age was 37.5 years (interquartile range 31-47). We describe a successful implementation and highlight the feasibility of a low-threshold, leave-behind naloxone program. Collaboration with multiple entities was a key component of the program's success.
Identifiants
pubmed: 36409939
pii: westjem.2022.8.56561
doi: 10.5811/westjem.2022.8.56561
pmc: PMC9683755
doi:
Substances chimiques
Naloxone
36B82AMQ7N
Narcotic Antagonists
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
952-957Références
MMWR Morb Mortal Wkly Rep. 2012 Feb 17;61(6):101-5
pubmed: 22337174
Am J Emerg Med. 2022 Jan;51:76-78
pubmed: 34688204
Prehosp Disaster Med. 2016 Dec;31(6):603-607
pubmed: 27640612
Addiction. 2015 Aug;110(8):1301-10
pubmed: 25917125
Drug Alcohol Depend. 2019 Nov 1;204:107571
pubmed: 31581024
Am J Public Health. 2014 Aug;104(8):e7-9
pubmed: 24922133
Prehosp Emerg Care. 2021 May-Jun;25(3):418-426
pubmed: 32420791
Ann Intern Med. 2020 Dec 1;173(11):941-944
pubmed: 32777183
J Addict Med. 2017 Sep/Oct;11(5):339-341
pubmed: 28787300
JAMA. 2015 Oct 13;314(14):1468-78
pubmed: 26461997
Clin Psychol Rev. 1998 Sep;18(6):689-711
pubmed: 9779329
BMJ Open. 2018 Jan 13;8(1):e019433
pubmed: 29331973
Prehosp Emerg Care. 2021 Mar-Apr;25(2):289-293
pubmed: 32208945
Int J Drug Policy. 2021 Sep;95:103402
pubmed: 34364179
Prev Med. 2015 Nov;80:5-9
pubmed: 25871819